Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

被引:6
|
作者
Sirakov, Ivo [1 ]
Rusenova, Nikolina [2 ]
Rusenov, Anton [3 ]
Gergova, Raina [1 ]
Strateva, Tanya [1 ]
机构
[1] Med Univ Sofia, Med Fac, Dept Med Microbiol, Sofia 1431, Bulgaria
[2] Trakia Univ, Fac Vet Med, Dept Vet Microbiol Infect & Parasit Dis, Stara Zagora 6000, Bulgaria
[3] Trakia Univ, Fac Vet Med, Dept Internal Noninfect Dis, Stara Zagora 6000, Bulgaria
关键词
ELISA; SARS-CoV-2; antibodies; humans; cats; SARS-COV-2; DIAGNOSIS;
D O I
10.3390/vetsci10010042
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Simple Summary The aim of the study was to verify whether the human DR-ELISA for the detection of antibodies against the agent of COVID-19 can be applied in cats, as well as to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. Therefore, 92 serum samples collected from 68 domestic and 24 stray cats were analyzed and compared with a multi-species ELISA kit. The results showed 83.33% positive results in stray cats and 41.18% in domestic cats, respectively, by both assays. Cats under 7 years had a five times higher risk than those over 7 years. The risk was seven times higher for stray cats than for domestic cats. Additionally, the results indicate the highest risk for cats in villages. This study demonstrates that human DR-ELISA may be helpful in monitoring the circulation of the virus in cats. The aim of this study was to verify whether the human DR-ELISA for the detection of anti-SARS-CoV-2 antibodies can be applied in cats, and to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. The study included 92 serum samples collected from 68 domestic and 24 stray cats aged from 3 months to 20 years of age in the period of January-June 2021. The samples originated from three regions in Bulgaria and from three places of inhabitance. DR-ELISA based on peroxidase-labeled SARS-CoV-2 N protein was employed to detect IgA, IgG and IgM antibodies in the samples. Subsequently, the results were compared with a commercially available multi-species ELISA kit. There was high seroprevalence (83.33%) in stray cats and 41.18% in domestic cats, confirmed by the human and veterinary ELISA kit. The positive cases in the regional cities were 42.86%, in small towns 50% and in villages 78.26%. Cats under 7 years had a five times higher risk than those over 7 years (p = 0.001). The risk was seven times higher for stray cats than for domestic cats (p = 0.001). In addition, the results indicate that the risk was the highest for cats in villages (p = 0.006) compared to cats in other places of inhabitance. This study demonstrates that human DR-ELISA may be successfully applied to monitor the circulation of SARS-CoV-2 in cats and other susceptible species. Cats might serve as sentinel animals for tracking the virus in nature and in inhabited areas (strays) and to discover asymptomatic cases in humans/owners.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] A Study of Factors that Impact the Production of Anti-SARS-CoV-2 Antibodies in Patients with Covid-19
    Hussein, Nawfal R.
    Balatay, Amer
    Mohammad, Ameen M.
    Dhama, Kuldeep
    Rasheed, Narin A.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (05): : 323 - 326
  • [22] High prevalence of SARS-CoV-2 antibodies and low prevalence of SARS-CoV-2 RNA in cats recently exposed to human cases
    Daigle, Laurence
    Khalid, Hattaw
    Gagnon, Carl A.
    Arsenault, Julie
    Bienzle, Dorothee
    Bisson, Sarah-Kim
    Blais, Marie-Claude
    Denis-Robichaud, Jose
    Forest, Caroline
    St-Sauveur, Valerie Grenier
    Koszegi, Marika
    MacNicol, Jennifer
    Nantel-Fortier, Nicolas
    Nury, Charlotte
    Prystajecky, Natalie
    Fraser, Erin
    Carabin, Helene
    Aenishaenslin, Cecile
    BMC VETERINARY RESEARCH, 2024, 20 (01)
  • [23] Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal
    Fonseca e Silva, Daniela
    Silva, Paulo Dias
    Torgal, Ana
    Braga, Sara
    Rocha, Diana
    Ochoa, Carlos
    Oliveira, Alvaro
    Rocha, Luis
    Dias, Joana Marinho
    Baldaque, Ines
    ACTA MEDICA PORTUGUESA, 2021, 34 (06): : 484 - 485
  • [24] Presence of Antibodies to SARS-CoV-2 in Domestic Cats in Istanbul, Turkey, Before and After COVID-19 Pandemic
    Yilmaz, Aysun
    Kayar, Abdullah
    Turan, Nuri
    Iskefli, Onur
    Bayrakal, Alper
    Roman-Sosa, Gleyder
    Or, Erman
    Tali, Hasan Emre
    Kocazeybek, Bekir
    Karaali, Ridvan
    Bold, Dashzeveg
    Sadeyen, Jean-Remy
    Lukosaityte, Deimante
    Chang, Pengxiang
    Iqbal, Munir
    Richt, Juergen A.
    Yilmaz, Huseyin
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [25] Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
    Carina C. Santos
    Fernanda W. de M. Lima
    Laio Magno
    Fabiane Soares
    Dulce Ferraz
    Alexandre Grangeiro
    Eliana Miura Zucchi
    Marie Préau
    Xavier Mabire
    Helen R. S. S. Matos
    Inês Dourado
    BMC Public Health, 23
  • [26] Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil
    Santos, Carina C.
    de M. Lima, Fernanda W.
    Magno, Laio
    Soares, Fabiane
    Ferraz, Dulce
    Grangeiro, Alexandre
    Zucchi, Eliana Miura
    Preau, Marie
    Mabire, Xavier
    Matos, Helen R. S. S.
    Dourado, Ines
    COBra Study Grp
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [27] Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic Review
    Mink, Sylvia
    Wilhelm, Fabian
    Cadamuro, Janne
    Reimann, Patrick
    Fraunberger, Peter
    REVIEWS IN MEDICAL VIROLOGY, 2025, 35 (02)
  • [28] Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021
    Stringhini, Silvia
    Zaballa, Maria-Eugenia
    Pullen, Nick
    Perez-Saez, Javier
    de Mestral, Carlos
    Loizeau, Andrea Jutta
    Lamour, Julien
    Pennacchio, Francesco
    Wisniak, Ania
    Dumont, Roxane
    Baysson, Helene
    Richard, Viviane
    Lorthe, Elsa
    Semaani, Claire
    Balavoine, Jean-Francois
    Pittet, Didier
    Vuilleumier, Nicolas
    Chappuis, Francois
    Kherad, Omar
    Azman, Andrew S.
    Posfay-Barbe, Klara
    Kaiser, Laurent
    Guessous, Idris
    EUROSURVEILLANCE, 2021, 26 (43)
  • [29] Investigation of Anti-SARS-CoV-2 IgG and IgM Antibodies in the Patients with COVID-19 by Three Different ELISA Test Kits
    Masayuki Nagasawa
    Yoshimi Yamaguchi
    Maki Furuya
    Yui Takahashi
    Reiko Taki
    Kaoru Nagata
    Shinichiro Suzaki
    Masayuki Kurosaki
    Namiki Izumi
    SN Comprehensive Clinical Medicine, 2020, 2 (9) : 1323 - 1327
  • [30] Prevalence of anti-SARS-CoV-2 antibodies and associated factors in healthcare workers of a Mexican Covid-19 hospital
    Herrera-Ortiz, Antonia
    Ugo Rojas-Delgado, Hector
    Garcia-Cisneros, Santa
    Xibille-Friedmann, Daniel X.
    Martinez-Barnetche, Jesus
    Olamendi-Portugal, Maria
    Minerva Gonzalez-Sanchez, Hilda
    Angel Sanchez-Aleman, Miguel
    SALUD PUBLICA DE MEXICO, 2022, 64 (04): : 348 - 356